New dietary methods to lower breast cancer risk linked to obesity
Novel dietary interventions for reducing obesity-associated breast cancer
This study is looking at how certain eating habits can help lower the risk of breast cancer for women who are overweight or obese, especially before and after menopause, by trying out a new method of eating that might work better than regular dieting.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-11007239 on NIH RePORTER |
What this research studies
This research investigates how specific dietary interventions can help reduce the risk of breast cancer in women who are overweight or obese. It focuses on understanding the relationship between obesity and breast cancer outcomes, particularly in premenopausal and postmenopausal women. The study will explore a novel approach called intermittent energy restriction, which may be more effective than traditional weight loss methods in improving health and cancer outcomes. Participants may engage in dietary modifications aimed at achieving sustainable weight loss and better metabolic health.
Who could benefit from this research
Good fit: Ideal candidates for this research are women aged 21 and older who are overweight or obese and at risk for breast cancer.
Not a fit: Patients who are not overweight or obese, or those who do not have a risk of breast cancer, may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved dietary strategies that significantly lower the risk of breast cancer in women with obesity.
How similar studies have performed: Previous research has shown that dietary interventions can positively impact weight loss and health outcomes, suggesting potential success for this novel approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Maclean, Paul S. — University of Colorado Denver
- Study coordinator: Maclean, Paul S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.